药房自动化市场按产品、药房类型、药房规模、应用、最终用户、分销管道和地区划分（2026 年至 2032 年）

药房自动化市场评估（2026-2032）

用药错误发生率的上升可能导致严重的健康后果，这是推动药局自动化发展的关键因素。预计到2024年，药局自动化市场规模将达到56.2亿美元，到2032年将达到95.9亿美元。

由于全球人口老化和慢性病增加导致处方药需求激增，预计 2026 年至 2032 年市场复合年增长率将达到 7.62%，这给药房等医疗机构在管理库存、配药和确保及时送达患者方面带来了挑战。

药房自动化市场定义/概述

药局自动化是指利用科技简化和自动化药局内药品处理、储存、调配和管理的各种流程。它结合了机器、机器人和软体系统，旨在执行先前由药剂师和技术人员手动执行的重复性任务。

药房自动化的主要目标是提高业务效率、提升准确性、减少用药错误，并最终提供更优质的患者照护。透过实现锭剂计数、库存管理和处方笺标籤等任务的自动化，药房可以显着降低人为错误的风险，同时让员工专注于更复杂、以患者为中心的工作。自1960年代末期简单的锭剂计数机问世以来，药房自动化已发展成为整合人工智慧和机器学习等先进技术的复杂系统，彻底改变了当今药房的运作方式。

减少用药错误的日益增长的需求将如何推动药房自动化市场的发展？

减少用药错误的需求日益增长，这是药房自动化市场的主要驱动力，因为用药错误会严重威胁病患安全。根据美国食品药物管理局(FDA) 的数据，光是在美国，每年就有约 150 万人因用药错误而受害。世界卫生组织 (WHO) 也估计，此类错误每年在全球整体导致 12.5 万例可预防死亡。这些令人担忧的统计数据凸显了对自动化系统的迫切需求，该系统能够提高配药和用药的准确性，并减少人为错误的可能性。

自动配药柜和机器人系统等药房自动化技术简化了各种药房业务，并显着降低了与手动流程相关的错误风险。根据美国安全用药实践研究所 (ISM) 的一项研究，大约 40% 的用药错误发生在续药作业期间，并且经常被忽视，直到导致不利事件发生。透过实施自动化解决方案，药局可以提高病患安全性和业务效率，同时减轻医护人员管理复杂用药方案的负担。随着医疗服务提供者寻求提高护理品质并最大限度地降低相关风险，对减少错误的关注正在推动药房自动化的发展。

高昂的初始资本成本将如何影响药局自动化技术的采用？

高昂的前期投资成本对药局自动化技术的采用有重大影响，也是许多医疗保健机构面临的一大障碍。实施这些系统通常需要大量资金用于设备购买、基础设施改造以及与现有工作流程的整合。一份报告显示，约80%的初级保健机构认为缺乏资金支持是实施自动化系统的主要障碍。

此外，美国食品药物管理局(FDA) 强调，由于用药错误会导致医疗成本增加，需要经济高效的解决方案。因此，儘管自动化的长期效益可能显着，但初期成本阻碍了许多药局的转型，减缓了整体市场的成长。

目录

第一章 引言

• 市场定义
• 细分市场
• 分析方法

第二章执行摘要

• 主要发现
• 市场概览
• 市集亮点

第三章市场概述

• 市场规模和成长潜力
• 市场趋势
• 市场驱动因素
• 市场限制
• 市场机会
• 波特五力分析

第四章药局自动化市场（按产品）

• 系统
• 软体
• 服务

第五章药局自动化市场（依药局类型）

• 独立的
• 连锁店
• 联邦政府

第六章药局自动化市场（以药局规模）

• 大型药房
• 中型药局
• 小型药房

第七章药局自动化市场（按应用）

• 分配和包装
• 药品储存
• 库存管理

第八章药局自动化市场（按最终用户）

• 住院药房
• 门诊病人药房
• 零售药局
• 网路药局
• 中央配药/邮购药房
• 药局福利管理人员

第九章药局自动化市场（依分销管道）

• 直接竞标
• 第三方经销商

第十章区域分析

• 北美洲
• 美国
• 加拿大
• 墨西哥
• 欧洲
• 英国
• 德国
• 法国
• 义大利
• 亚太地区
• 中国
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中东和非洲
• 南非
• 沙乌地阿拉伯
• 阿拉伯聯合大公国

第十一章 市场动态

• 市场驱动因素
• 市场限制
• 市场机会
• 感染疾病 -19对市场的影响

第十二章竞争格局

• 主要企业
• 市场占有率分析

第十三章 公司简介

• McKesson Corporation
• Omnicell, Inc.
• Cerner Corporation
• Swisslog Holding AG
• BD（Becton, Dickinson and Company）
• Capsa Healthcare
• Parata Systems LLC
• ScriptPro LLC
• ARxIUM Inc.
• TCGRx
• Talyst
• Baxter International
• Health Robotics SRL
• Yuyama , Ltd.
• Pearson Medical Technologies
• Kirby Lester
• Willach Pharmacy Solutions
• Innovation Associates
• KUKA AG

第十四章 市场展望与机会

• 新兴技术
• 未来市场趋势
• 投资机会

第十五章 附录

• 简称列表
• 来源和参考文献

Pharmacy Automation Market Valuation - 2026-2032

The rising incidence of medication errors, which can lead to severe health consequences, is a significant driver for pharmacy automation. The pharmacy automation market size is estimated at USD 5.62 Billion in 2024, and is expected to reach USD 9.59 Billion by 2032.

The aging global population and rising chronic diseases have led to a surge in prescription medication demand, posing challenges for healthcare facilities like pharmacies in managing inventory, dispensing medications, and ensuring timely patient delivery enabling the market grow at a CAGR of 7.62% from 2026 to 2032.

Pharmacy Automation Market: Definition/ Overview

Pharmacy automation refers to the use of technology to streamline and automate various processes involved in the handling, storage, dispensing, and management of medications within a pharmacy. This includes a combination of machines, robotics, and software systems designed to perform repetitive tasks that would otherwise be done manually by pharmacists and technicians.

The primary goal of pharmacy automation is to enhance operational efficiency, improve accuracy, reduce medication errors, and ultimately provide better patient care. By automating tasks such as counting pills, managing inventory, and labeling prescriptions, pharmacies can significantly decrease the risk of human error while also freeing up staff to focus on more complex and patient-centered activities. Since its inception in the late 1960s with simple pill- counting machines, pharmacy automation has evolved into sophisticated systems that integrate advanced technologies like artificial intelligence and machine learning, transforming how pharmacies operate today.

What Role does the Increasing Need to Minimize Medication Errors Play in Driving the Pharmacy Automation Market?

The increasing need to minimize medication errors significantly drives the pharmacy automation market, as these errors pose serious risks to patient safety. According to the U.S. Food and Drug Administration (FDA), medication errors harm approximately 1.5 million people annually in the United States alone. Additionally, the World Health Organization (WHO) estimates that these errors lead to 125,000 preventable deaths each year globally. Such alarming statistics underscore the urgent need for automated systems that enhance accuracy in medication dispensing and management, thereby reducing the likelihood of human error.

Pharmacy automation technologies, such as automated dispensing cabinets and robotic systems, streamline various pharmacy operations, significantly decreasing the risk of mistakes associated with manual processes. A study by the Institute for Safe Medication Practices found that about 40% of medication errors occur during the refill process, often going unnoticed until they result in adverse events. By implementing automation solutions, pharmacies can improve patient safety and operational efficiency while alleviating the burden on healthcare professionals managing complex medication regimens. This focus on error reduction is propelling the growth of pharmacy automation as healthcare providers seek to enhance care quality and minimize associated risks.

How do High Initial Investment Costs Impact the Adoption of Pharmacy Automation Technologies?

High initial investment costs significantly impact the adoption of pharmacy automation technologies, posing a considerable barrier for many healthcare providers. Implementing these systems often requires substantial financial outlay for equipment, infrastructure modifications, and integration with existing workflows. According to a report, around 80% of primary care setups cite a lack of financial support as a major hindrance to adopting automation systems.

Additionally, the U.S. Food and Drug Administration (FDA) has highlighted that medication errors lead to increased healthcare costs, emphasizing the need for cost-effective solutions. Consequently, while the long-term benefits of automation may be substantial, the upfront costs deter many pharmacies from making the transition, slowing overall market growth.

Category-Wise Acumens

How do Inpatient Pharmacy Automation Systems Enhance the Tracking and Management of Controlled Substances?

Inpatient pharmacy automation systems enhance the tracking and management of controlled substances by providing real-time visibility and accountability throughout the medication-use process. For instance, a study at Houston Methodist Hospital demonstrated that implementing mobile medication tracking technology improved documentation accuracy significantly, with missing documents dropping from 29 to zero after transitioning from a paper-based system.

This technology ensured that 140 out of 141 medications had receiving personnel information documented electronically, improving the capture rate of medication delivery personnel from 67.4% to 92.9%. Such advancements minimize the risk of diversion and enhance compliance with regulations set by the U.S. Drug Enforcement Administration (DEA).

Additionally, automated systems streamline the ordering, storing, and dispensing processes for controlled substances, which helps reduce human error and improve overall efficiency. The FDA emphasizes the importance of meticulous record-keeping for controlled substances to prevent misuse, and automated systems facilitate this by providing accurate tracking and reporting capabilities. By integrating these technologies into hospital workflows, pharmacies can ensure a reliable chain of custody for controlled substances, thereby enhancing patient safety and supporting healthcare providers in maintaining compliance with regulatory requirements.

What Role does Regulatory Compliance Play in Motivating Large Size Pharmacies to Adopt Pharmacy Automation Technologies?

Regulatory compliance plays a crucial role in motivating large size pharmacies to adopt pharmacy automation technologies. With stringent regulations set by agencies such as the U.S. Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS), large pharmacies must ensure they meet various safety and quality standards. For instance, the FDA emphasizes the importance of accurate record-keeping and reporting, which can be labor-intensive and prone to human error when done manually. Automation systems streamline data collection and reporting processes, significantly reducing the risk of compliance issues.

Moreover, automated systems can monitor access to protected health information (PHI) and alert staff to potential compliance violations, thereby enhancing accountability. The Health Insurance Portability and Accountability Act (HIPAA) mandates strict data privacy measures, and automation aids in maintaining these standards by ensuring secure handling of sensitive information. By leveraging automation technologies, large pharmacies can improve their compliance efforts, reduce the likelihood of costly penalties, and enhance overall operational efficiency, making them more agile in responding to regulatory changes.

Country/Region-wise Acumens

What Factors Contribute to the Rapid Growth of Pharmacy Automation Technologies in the Asia Pacific Region?

The rapid growth of pharmacy automation technologies in the Asia Pacific region is driven by several key factors. A significant contributor is the aging population, with projections indicating that by 2025, Asia will have 456 million seniors aged 65 or older, representing 10% of its population. This demographic shift increases the demand for efficient medication management systems.

Additionally, government initiatives aimed at improving healthcare access and quality are crucial; for instance, the Asian Development Bank (ADB) has committed over USD 20 Billion in assistance to enhance healthcare systems in response to challenges posed by the COVID-19 pandemic. These factors, combined with rising consumer expectations and technological advancements, create a conducive environment for the swift adoption of pharmacy automation technologies across the region.

What Technological Innovations are Driving the Adoption of Pharmacy Automation Systems in North America?

Technological innovations are pivotal in driving the adoption of pharmacy automation systems in North America. Key advancements include robotic dispensing systems, which enhance accuracy by automating the counting, labeling, and dispensing of medications. For instance, the U.S. Food and Drug Administration (FDA) reports that medication errors contribute to approximately 100,000 adverse events annually, highlighting the urgent need for solutions that minimize such risks.

Additionally, artificial intelligence (AI) and machine learning are being integrated into inventory management systems to optimize stock levels and reduce waste. The Centers for Medicare & Medicaid Services (CMS) also supports the use of automation to improve patient safety and operational efficiency. As healthcare providers increasingly focus on minimizing medication errors and enhancing workflow, these technological innovations are essential in transforming pharmacy operations, ultimately leading to better patient outcomes and satisfaction.

Competitive Landscape

The competitive landscape of the pharmacy automation market is characterized by intense competition among a diverse array of players, including established pharmaceutical companies, medical device manufacturers, and technology firms.

Some of the prominent players operating in the pharmacy automation market include:

• McKesson Corporation
• Omnicell,
• BD (Becton, Dickinson and Company)
• AmerisourceBergen Corporation
• Swisslog Healthcare
• Capsa Healthcare
• Talyst,
• Cerner Corporation
• Baxter International
• ScriptPro LLC
• ARxIUM,
• Health Robotics SRL
• Yuyama , Ltd.
• ScriptPro LLC
• TCGRx
• Pearson Medical Technologies
• Kirby Lester
• Willach Pharmacy Solutions
• Innovation Associates
• KUKA AG

Latest Developments

• In April 2024, Omnicell Launch XR2 Automated Central Pharmacy System, which offers a fully automated approach to medication inventory management, enhancing patient safety through 100% barcode scanning and reducing expired medication
• In January 2024, AmerisourceBergen completed its acquisition of PharmaLex Holding GmbH, enhancing its specialty services and expanding its platform for pharmaceutical manufacturer services, which includes pharmacy automation

Pharmacy Automation Market, By Category

• Product:
• Systems
• Software
• Services
• Pharmacy Type:
• Independent
• Chain
• Federal
• Pharmacy Size:
• Large Size Pharmacy
• Medium Size Pharmacy
• Small Size Pharmacy
• Application:
• Drug Dispensing and Packaging
• Drug Storage
• Inventory Management
• End-User:
• Inpatient Pharmacies
• Outpatient Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Central Fill/Mail Order Pharmacies
• Pharmacy Benefit Management Organizations
• Distribution Channel:
• Direct Tender
• Third Party Distributor
• Region:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

TABLE OF CONTENTS

1. INTRODUCTION

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Pharmacy Automation Market, By Product

• Systems
• Software
• Services

5. Pharmacy Automation Market, By Pharmacy Type

• Independent
• Chain
• Federal

6. Pharmacy Automation Market, By Pharmacy Size

• Large Size Pharmacy
• Medium Size Pharmacy
• Small Size Pharmacy

7. Pharmacy Automation Market, By Application

• Drug Dispensing and Packaging
• Drug Storage
• Inventory Management

8. Pharmacy Automation Market, By End-User

• Inpatient Pharmacies
• Outpatient Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Central Fill/Mail Order Pharmacies
• Pharmacy Benefit Management Organizations

9. Pharmacy Automation Market, By Distribution Channel

• Direct Tender
• Third Party Distributor

10. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

11. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

12. Competitive Landscape

• Key Players
• Market Share Analysis

13. Company Profiles

• McKesson Corporation
• Omnicell, Inc.
• Cerner Corporation
• Swisslog Holding AG
• BD (Becton, Dickinson and Company)
• Capsa Healthcare
• Parata Systems LLC
• ScriptPro LLC
• ARxIUM Inc.
• TCGRx
• Talyst
• Baxter International
• Health Robotics SRL
• Yuyama , Ltd.
• Pearson Medical Technologies
• Kirby Lester
• Willach Pharmacy Solutions
• Innovation Associates
• KUKA AG

14. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

15. Appendix

• List of Abbreviations
• Sources and References